Roche, Bristol-Myers Melanoma Therapies Boost Survival

238 views · Published 6 June 2011 · 2:05 · Indexed 20 November 2026

Channel: Bloomberg Originals · 2011 · Entertainment

Watch on YouTube

June 6 (Bloomberg) -- An experimental drug from Roche Holding AG and Daiichi Sankyo Co. prolonged the lives of patients with melanoma in a study, a result that may lead to a second new treatment to fight deadly skin cancer. Shannon Pettypiece reports from the American Society of Clinical Oncology meeting in Chicago on Bloomberg Television's "In the Loop." (Source: Bloomberg)

More from this channel